Advertisement

Topics

ERYtech Pharma Company Profile

00:36 EST 23rd November 2017 | BioPortfolio

ERYtech Pharma is a specialty pharma company developing innovative therapeutic solutions based on its proprietary technology and expertise in the physiological properties of erythrocytes. The company addresses serious pathologies, orphan indications or sub-populations of patients, particularly in the fields of haematology, cancer and metabolic diseases.


News Articles [623 Associated News Articles listed on BioPortfolio]

ERYTECH Announces Pricing of Global Offering and Approval to List on Nasdaq Global Select Market

Regulatory News: NOT FOR DISTRIBUTION IN AUSTRALIA, CANADA AND JAPAN ERYTECH Pharma (Paris:ERYP) (ADR:EYRYY) ("ERYTECH" or the "Company"), a clinical-stage biopharmaceutical company developing inn...

Erytech Pharma privately raises €70.5mm

Erytech Pharma SA raised €70.5mm ($84.5mm) through the private sale of 3mm new ordinary shares to undisclosed investors. Funds will support pipeline development activity, including an upcoming Phase...

ERYTECH Announces Launch of Proposed Global Offering and NASDAQ Listing

Regulatory News: ERYTECH Pharma (Euronext Paris: ERYP) (ADR: EYRYY) ("ERYTECH" or the "Company") (Paris:ERYP) (ADR:EYRYY) a clinical-stage biopharmaceutical company developing innovative therapies...

ERYTECH Pharma: Information Related to Total Number of Voting Rights and Shares Composing the Share Capital -July 31st, 2017

Article 223-16 of general regulation of French Autorité des Marchés Financiers Regulatory News: ERYTECH Pharma (Paris:ERYP) (ADR:EYRYY): Listing market: Euronext Paris from EuronextMarket segment ....

ERYTECH überträgt Webcast von Präsentation bei Jefferies London Healthcare Conference 2017

ERYTECH Pharma (Nasdaq und Euronext: ERYP), ein Biopharmaunternehmen, das sich mit der klinischen Phase der Entwicklung innovativer Therapien durch Einkapselung von Arzneimittelwirkstoffen in rote...

Erytech Pharma: Monthly Information Related to Total Number of Voting Rights and Shares Composing the Share Capital - November 16, 2017

Article 223-16 of general regulation of French Autorité des Marchés Financiers Regulatory News: Erytech Pharma (Euronext: ERYP- Nasdaq: ERYP): Listing markets: Euronext Paris from Euronext (Market.....

Erytech Announces Trading Resumption of Its Ordinary Shares on Euronext Paris

Regulatory News: NOT FOR DISTRIBUTION IN AUSTRALIA, CANADA OR JAPAN ERYTECH Pharma (Paris:ERYP) (ADR:EYRYY) (Euronext Paris: ERYP) ("ERYTECH" or "the Company") announces trading resumption of its ...

Erytech completes $101.4mm IPO in US

Erytech Pharma SA (developing treatments for rare cancers and orphan diseases) netted $101.4mm through its US initial public offering of 4.7mm American Depositary Shares (representing 4.7mm ordinary s...

Drugs and Medications [238 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

PubMed Articles [23 Associated PubMed Articles listed on BioPortfolio]

Delivering advanced therapies: The big pharma approach.

After two decades of focused development and some recent clinical successes, cell and gene therapy (CGT) is emerging as a promising approach to personalized medicines. Genetically engineered cells as ...

Bioanalytical outsourcing: transitioning from Pharma to CRO.

AI-powered drug discovery captures pharma interest.

Clinical Trials Series - Large Pharma.

Arkansas execution proceeds as pharma companies lose battle to stop use of their drugs.

Clinical Trials [75 Associated Clinical Trials listed on BioPortfolio]

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Sofodelevier 400...

To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions

To demonstrate the relative bioavailability of Cilostazol 50 mg tablets under fasting conditions.

Companies [725 Associated Companies listed on BioPortfolio]

ERYtech Pharma

ERYtech Pharma is a specialty pharma company developing innovative therapeutic solutions based on its proprietary technology and expertise in the physiological properties of eryth...

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and ...

LEO Pharma Inc.

LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more t...

Laurantis Pharma Oy

Laurantis Pharma Oy is a privately held specialty pharmaceutical company based in Finland. Laurantis Pharma Oy was formed in 2010 through the merger of two independent companies, ...

FranceMed Pharma

FranceMed Pharma is a Research, Development, FMCG Manufacturer and Global Marketing Company established since 1981. FranceMed Pharma owns Magicool® brand and the world-wide patents and technology. Fr...

More Information about "ERYtech Pharma" on BioPortfolio

We have published hundreds of ERYtech Pharma news stories on BioPortfolio along with dozens of ERYtech Pharma Clinical Trials and PubMed Articles about ERYtech Pharma for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ERYtech Pharma Companies in our database. You can also find out about relevant ERYtech Pharma Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...


Corporate Database Quicklinks



Searches Linking to this Company Record